Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
MEK116833 : Essai de phase 1-2 évaluant la tolérance, la pharmacocinétique, la pharmacodynamie et l’activité clinique de l’association du trametinib, du dabrafenib, et du panitumumab, chez des patients ayant un cancer colorectal avancé ou métastatique et porteurs d’une mutation BRAF V600E. [essai clos aux inclusions] https://www.kusajili.com:443/Trial/NjE5Quf0B061xYyTo80wsQ%24mek116833-essai-de-phase-1-2-evaluant-la-tolerance-la-pharmacocinetique-la-pharmacodynamie-et-lactivite-clinique-de-lassociatio
I have read and accept the terms of use of the site and the Privacy Policy
Send your message